學院教職員
教學人員
潘國明教授
Prof. Paul Kwok-ming POON
FHKCCM, FFPH, FHKAM(Community Medicine), FRACGP, FHKCFP, MFM(Clin)(Monash), PgDipPD (Cardiff), Dip Med (CUHK), MBChB(CUHK)
公共衛生專業應用副教授
學術委任
-
Programme Director, Master of Public Health Programme
個人簡介
Prof. Poon is a registered medical specialist in public health medicine in Hong Kong, and he is also a family medicine fellow of The Royal Australian College of General Practitioners (RACGP) and The Hong Kong College of Family Physicians (HKCFP). He has experience in practising public health medicine in the Department of Health of Hong Kong for more than 10 years. He completed the Field Epidemiology Training Programme (FETP) of Hong Kong in 2015. Prof. Poon also had chance to work in the Regional Office of the Western Pacific (WPRO) of the WHO. He is an examiner, a trainer and a member of the Public Health Medicine Subspecialty Board of the Hong Kong College of Community Medicine (HKCCM), and a diplomate examiner for the Faculty of Public Health (FPH) of the United Kingdom. Prof. Poon is the chief examiner for the licensing examination in professional knowledge (Medical Ethics/Community Medicine) of the Medical Council of Hong Kong and a member of the Prevention of Legionnaires’ Disease Committee of the HKSAR Government. Prof. Poon is also the Programme Director of the Master of Public Health (MPH) Programme of CUHK.
研究方向
-
Health Literacy
-
Infectious Disease Epidemiology
-
Vaccinology
-
Chronic Diseases
部份學術文章
-
Paul Kwok-ming Poon, Ngai-sze Wong, Wai-shing Leung, Bonnie Chun-kwan Wong, Tsz-shan Kwong, Tsz-ho Kwan, Grace Chung-yan Lui, Owen Tak-yin Tsang, Man-po Lee, Ka-hing Wong, Shui-shan Lee.The differential impacts of early detection and accelerated antiretroviral therapy on the epidemiologic trend of sexually acquired HIV infection in Hong Kong. PLOS ONE 17(9): e0274498. https://doi.org/10.1371/journal.pone.0274498
-
Poon, P., Zhou, W., Chan, D., Kwok, K. O., & Wong, S. (2021). Recommending COVID-19 Vaccines to Patients: Practice and Concerns of Frontline Family Doctors. Vaccines, 9(11), 1319. https://doi.org/10.3390/vaccines9111319
-
Paul KM Poon. (2021). COVID-19 vaccination intention in the Western Pacific Region - insights from Japan. The Lancet regional health. Western Pacific, 14, 100245. https://doi.org/10.1016/j.lanwpc.2021.100245
-
Poon, P., Tam, K. W., Zhang, D., Yip, B., Woo, J., & Wong, S. (2022). Handgrip strength but not SARC-F score predicts cognitive impairment in older adults with multimorbidity in primary care: a cohort study. BMC geriatrics, 22(1), 342. https://doi.org/10.1186/s12877-022-03034-2
-
Poon PKM, Tam KW, Lam T, Luk AKC, Chu WCW, Cheung P, Wong SYS and Sung JJY (2023) Poor health literacy associated with stronger perceived barriers to breast cancer screening and overestimated breast cancer risk. Front. Oncol. 12:1053698. doi: 10.3389/fonc.2022.1053698
-
Lee, E. K., Poon, P.**, Yu, C. P., Lee, V. W., Chung, V. C., & Wong, S. Y. (2022). Controlled-release oral melatonin supplementation for hypertension and nocturnal hypertension: A systematic review and meta-analysis. Journal of clinical hypertension (Greenwich, Conn.), 10.1111/jch.14482. Advance online publication. https://doi.org/10.1111/jch.14482 (**co-first author)
-
Lee, Eric Kam-Pui; Poon, Paul**; Bo, Yacong; Zhu, Meng-Ting; Yu, Chun-Pong; Ngai, Alfonse Ch; Wong, Martin Cs; Wong, Samuel Ys. Global Burden, Regional Differences, Trends, and Health Consequences of Medication Non-adherence in Patients with Hypertension during 2010-2020: A Systematic Review and Meta-Analysis. Journal of Hypertension: June 2022 - Volume 40 - Issue Suppl 1 - p e309. https://doi.org/10.1097/01.hjh.0000838756.84237.8c (**co-first author)
-
Hu P, Zhang D, Wong SYS, Woo J, Yu R, Yip BHK, Poon PKM. The effect of social isolation on sarcopenia: a longitudinal study among the middle-aged and older population in China. Gerontology. 2023 Jan 31. doi: 10.1159/000529443
-
Wei Y, Jia KM, Zhao S, Hung CT, Mok CKP, Poon PKM, Man Leung EY, Wang MH, Yam CHK, Chow TY, Guo Z, Yeoh EK, Chong KC. Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron. JAMA Netw Open. 2023 Feb 1;6(2):e2254777. doi: 10.1001/jamanetworkopen.2022.54777